UniFirst
UNF
252.31
+0.59
+0.23%
UniFirst
US · UNF
#2195 by market cap
Listed 1970
252.31
+0.59
+0.23%
Live - 5344 symbols - heartbeat 124s ago
· 2026-10-08 08:37
Pre-market
252.31
0.00%
After-hours
252.31
0.00%
Overnight
253.52
+0.48%
- Market cap
- 4.56B
- P/E (TTM)i
- 39.86
- P/Bi
- 2.08
- EPSi
- 7.98
- Div yieldi
- 0.57%
- 52W posi
- 66%
Reader sentiment
Are you bullish or bearish on UNF?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 6.91, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.20% YoY
Margins
- Gross margin
- 36.59%
- Operating margin
- 7.59%
- Net margin
- 6.10%
Key ratios & quality
- PEG ratioi
- 3.12
- Altman Z-Scorei
- 6.91
PEG uses trailing P/E against the 3-year net income growth rate (12.76%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.70B | 1.81B | 1.80B | 1.83B | 2.00B | 2.23B | 2.43B | 2.43B |
| Gross profit | 639.77M | 670.18M | 639.23M | 684.94M | 694.37M | 751.75M | 847.60M | 889.95M |
| Selling & admin expenses | 360.73M | 334.84M | 361.80M | 383.16M | 451.24M | 496.92M | 522.59M | 565.10M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 182.38M | 232.01M | 172.73M | 195.83M | 134.35M | 133.60M | 183.58M | 184.50M |
| Pretax profit | 187.25M | 237.92M | 177.89M | 196.87M | 134.33M | 138.84M | 189.38M | 195.38M |
| Tax | 23.35M | 58.79M | 42.12M | 45.76M | 30.92M | 35.16M | 43.91M | 47.10M |
| Net profit | 163.90M | 179.13M | 135.77M | 151.11M | 103.40M | 103.67M | 145.47M | 148.27M |
| Basic EPS | 9 | 10 | 7 | 8 | 6 | 6 | 8 | 8 |
| Diluted EPS | 8.21 | 9.33 | 7.13 | 7.94 | 5.46 | 5.53 | 7.77 | 7.98 |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Revenue | 602.22M | 610.78M | 614.45M | 621.32M | 622.51M | 634.40M |
| Gross profit | 208.07M | 225.59M | 232.44M | 228.29M | 218.82M | 234.73M |
| Selling & admin expenses | 141.91M | 142.69M | 146.98M | 147.81M | 157.41M | 175.93M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 31.21M | 48.18M | 49.58M | 45.31M | 26.01M | 23.03M |
| Pretax profit | 32.63M | 53.40M | 51.41M | 46.98M | 27.34M | 24.44M |
| Tax | 8.17M | 13.72M | 10.38M | 12.62M | 6.86M | 4.53M |
| Net profit | 24.46M | 39.68M | 41.03M | 34.36M | 20.48M | 19.92M |
| Basic EPS | 1 | 2 | 2 | 2 | 1 | 1 |
| Diluted EPS | 1.31 | 2.13 | 2.23 | 1.89 | 1.13 | 1.09 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 784.80M | 913.79M | 969.33M | 1.10B | 1.06B | 840.12M | 915.68M | 924.60M |
| Cash & ST investments | 270.51M | 385.34M | 474.84M | 512.87M | 376.40M | 89.60M | 175.08M | 209.17M |
| Inventory | 264.57M | 285.23M | 260.55M | 325.12M | 370.85M | 396.66M | 394.88M | 372.92M |
| Total assets | 1.84B | 2.05B | 2.20B | 2.38B | 2.43B | 2.57B | 2.70B | 2.78B |
| Total current liabilities | 198.46M | 189.84M | 210.10M | 254.67M | 243.75M | 267.23M | 281.44M | 290.40M |
| Short-term debt | -- | -- | 12.57M | 12.99M | 13.60M | 17.74M | 18.24M | 17.85M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 378,419,000.00 | 406,090,000.00 | 457,898,000.00 | 508,113,000.00 | 512,101,000.00 | 566,015,000.00 | 587,902,000.00 | 609,198,000.00 |
| Total equity | 1.46B | 1.64B | 1.74B | 1.87B | 1.92B | 2.00B | 2.11B | 2.17B |
| Retained earnings | 1.41B | 1.59B | 1.68B | 1.81B | 1.85B | 1.93B | 2.03B | 2.08B |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Total current assets | 936.85M | 937.87M | 924.60M | 872.72M | 903.09M | 919.94M |
| Cash & ST investments | 200.98M | 211.91M | 209.17M | 129.54M | 157.46M | 168.88M |
| Inventory | 385.33M | 376.43M | 372.92M | 380.37M | 383.73M | 385.84M |
| Total assets | 2.73B | 2.76B | 2.78B | 2.75B | 2.80B | 2.82B |
| Total current liabilities | 277.56M | 266.95M | 290.40M | 263.95M | 290.41M | 295.69M |
| Short-term debt | 17.23M | 17.84M | 17.85M | 18.99M | 20.23M | 20.82M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 589,806,000.00 | 585,236,000.00 | 609,198,000.00 | 590,100,000.00 | 617,106,000.00 | 622,649,000.00 |
| Total equity | 2.14B | 2.17B | 2.17B | 2.16B | 2.18B | 2.20B |
| Retained earnings | 2.07B | 2.09B | 2.08B | 2.08B | 2.09B | 2.11B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 230.07M | 282.14M | 286.68M | 212.30M | 122.65M | 215.76M | 295.27M | 296.87M |
| Depreciation & amortization | 96.66M | 103.33M | 104.70M | 105.96M | 108.78M | 121.23M | 141.43M | 140.36M |
| Free cash flow | 117.33M | 162.33M | 169.97M | 78.66M | -21.67M | 43.77M | 134.85M | 142.53M |
| Dividends paid | -4.22M | -8.26M | -15.70M | -18.15M | -20.79M | -22.10M | -23.35M | -24.63M |
| Stock buybacks / issuance | -146.01M | -30.52M | -21.75M | -11.22M | -44.41M | 0 | -23.78M | -70.90M |
| Ending cash balance | 270.51M | 385.34M | 474.84M | 512.87M | 376.40M | 79.44M | 161.57M | 203.50M |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Operating cash flow | 70.18M | 68.18M | 100.39M | 14.85M | 73.62M | 50.88M |
| Depreciation & amortization | 34.95M | 34.72M | 35.88M | 35.18M | 35.39M | 35.77M |
| Free cash flow | 37.66M | 24.44M | 55.87M | -24.03M | 35.22M | 21.19M |
| Dividends paid | -6.26M | -6.25M | -6.22M | -6.13M | -6.34M | -6.34M |
| Stock buybacks / issuance | -6.16M | -13.07M | -45.30M | -32.74M | 0 | 0 |
| Ending cash balance | 192.17M | 211.91M | 203.50M | 123.98M | 151.79M | 163.23M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 11.23 | 11.53 | 8.03 | 8.36 | 5.46 | 5.29 | 7.07 | 6.93 |
| ROA %i | 8.95 | 9.21 | 6.39 | 6.60 | 4.30 | 4.15 | 5.52 | 5.42 |
| ROIC %i | 10.90 | 11.09 | 7.55 | 8.06 | 5.21 | 4.89 | 6.59 | 6.38 |
| 5-year avg ROE %i | 9.43 | 9.53 | 9.06 | 8.82 | 8.92 | 7.73 | 6.84 | 6.62 |
| EBIT margin %i | 10.75 | 12.82 | 9.57 | 10.72 | 6.71 | 5.98 | 7.56 | 7.59 |
| FCF / sales %i | 6.92 | 8.97 | 9.42 | 4.31 | -- | 1.96 | 5.56 | 5.86 |
| Current ratioi | 3.95 | 4.81 | 4.61 | 4.33 | 4.36 | 3.14 | 3.25 | 3.18 |
| Quick ratioi | 2.37 | 3.10 | 3.17 | 2.83 | 2.57 | 1.38 | 1.61 | 1.70 |
| Debt / assetsi | -- | 0.00 | 1.90 | 1.81 | 2.13 | 2.52 | 2.55 | 2.61 |
| LT debt / equityi | -- | -- | 1.68 | 1.61 | 1.99 | 2.35 | 2.40 | 2.52 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 5.21 | 7.22 | 4.28 | 2.49 | 3.41 | 7.37 | 9.95 | 6.73 |
| Net income CAGR (3Y) %i | 9.66 | 12.74 | 24.59 | -2.67 | -16.74 | -8.60 | -1.26 | 12.76 |
| FCF CAGR (3Y) %i | -2.29 | 14.06 | 15.71 | -12.48 | -- | -36.38 | 19.68 | -- |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| ROE %i | 7.17 | 7.15 | 6.93 | 6.50 | 6.27 | 5.30 |
| ROA %i | 5.61 | 5.61 | 5.42 | 5.12 | 4.90 | 4.15 |
| ROIC %i | 6.62 | 6.57 | 6.38 | 5.98 | 5.77 | 4.85 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.72 | 7.69 | 7.59 | 7.12 | 6.85 | 5.77 |
| FCF / sales %i | 6.66 | 6.12 | 5.86 | 3.84 | 3.71 | 3.54 |
| Current ratioi | 3.38 | 3.51 | 3.18 | 3.31 | 3.11 | 3.11 |
| Quick ratioi | 1.74 | 1.85 | 1.70 | 1.60 | 1.55 | 1.57 |
| Debt / assetsi | 2.59 | 2.71 | 2.61 | 2.80 | 2.85 | 3.02 |
| LT debt / equityi | 2.50 | 2.62 | 2.52 | 2.68 | 2.73 | 2.92 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Uniform & Facility Service Solution is the largest reported line at 90.75% of revenue, across 3 reported segments.
- The next-largest line, First Aid & Safety Solution, is a distant second at 4.86% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Uniform & Facility Service Solution90.75%
First Aid & Safety Solution4.86%
Other4.39%
Quote time 2026-10-08 08:37:56 · For reference only, not investment advice and not tailored to your situation.